Infection with the helicobacter pylori bacteria, usually referred to as H. pylori, is common, affecting almost half of all people in the United States at some point in their lifetime. In most cases, ...

Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach and small bowel. It is often symptomless, but it can increase the risk of ulcers, gastritis, and cancer, all of which can ...

Several Twitter users on Thursday, November 25, took to the micro-blogging site to narrate their experiences with bacteria Helicobacter pylori (H. Pylori). The users observed that H. Pylori seems to ...

MONDAY, Sept. 9, 2024 (HealthDay News) -- In a clinical practice guideline issued by the American College of Gastroenterology and published in the September issue of the American Journal of ...

It used to be thought that stomach and duodenal (outlet of the stomach) irritation and ulcers were caused by stress and spicy foods. Then, in the late 1970s and early ’80s two researchers in Australia ...

Dear Pharmacist: I took the stool test you recommended called "GI Effects" by Metametrix Labs, and it's positive for high levels of a bacteria called H. pylori. My doctor is treating me aggressively ...

Dear Pharmacist: I took the stool test you recommended called “GI Effects” by Metametrix Labs, and it’s positive for high levels of a bacteria called H. Pylori. My doctor is treating me aggressively ...

Background and Aim: Common endoscopic findings in stomachs with Helicobacter pylori infections include antral nodularity, thickened gastric folds, and visible submucosal vessels. These findings are ...

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...

What if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable populations? A new study from Sylvester Comprehensive Cancer Center at the University of ...

Bismuth quadruple therapy for 14 days is preferred regimen for treatment-naive patients when antibiotic susceptibility is unknown. William D. Chey, MD, from Michigan Medicine in Ann Arbor, and ...